Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) received FDA approval for its generic version of Ipratropium Bromide HFA Inhalation Aerosol 17mcg/actuation, the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE